Home
Market Opportunities & Technology Trends in Point of Care Diagnostics
23 February - 24 February 2005
Market Opportunities & Technology Trends in Point of Care Diagnostics
In recent years there has been a definitive shift in the use of POCT with a predictive market growth expectancy of 27% in the next five years. SAE Media Group recognises the importance of this expanding market and subsequently has organised a forum in which leading experts from the pharmaceutical and diagnostics industry will evaluate the latest developments in this arena. This 2nd annual conference on Market Opportunities and Technology Trends in Point of Care Diagnostics will continue the series of well-received events run specifically for the Diagnostics industry

This conference will explore the rapid growth of POCT in terms of technology advancements and health care economics, with a specific focus on glucose, coagulation, infectious disease, drugs of abuse and critical care testing. In addition, it will critically analyse the growth of the global market, assessing the drivers and shapers, and ascertain the significance for individual companies.

A unique opportunity to learn from leading industry experts including:

  • Professor Christopher Price, Vice President, Global Clinical Research, Diagnostics Division, Bayer Healthcare
  • Dr Greg Shipp, Vice President, Medical Affairs, Abbott Point of Care (I-STAT) Division
  • Giuseppe Minola, Head, Near Patient Testing, Business Area Near Patient Testing, Roche Diagnostics
  • Dr Raimund Sterz, Director, Health Economics & Outcomes Research, Abbott
  • Dr Thomas Mann, Clinical Director, National Implementation Team, Commercial Directorate, Department of Health
  • Svein Lien, Chief Executive Officer, Axis-Shield
  • Professor Sam Machin, Consultant Haematologist, University College London Hospitals
  • Clint Severson, President & Chief Executive, Abaxis

Key issues that will be addressed at the Conference include:

  • CURRENT MARKET TRENDS AND DRIVERS: Analyse the latest trends and emerging technologies in the point of care industry
  • NOVEL POINT OF CARE DIAGNOSTIC TESTS: Consider their effectiveness in the sector
  • HEALTH OUTCOMES: Hear about the advantages of point of care testing within an economic and clinical setting
  • PRICING AND REIMBURSEMENT ISSUES: Understand how point of care diagnostics are funded and the subsequent impact on the industry and Government
  • KEY INDUSTRY PERSONNEL: Meet the leaders in the field, make valuable contacts and learn from their experience and expertise

Conference agenda

clock

13:30

Registration and Coffee

clock

13:45

Introduction

  • The scope of POCT
  • Where does point of care stand in 2005 – where will it be in 2010?
  • Today’s point of care marketplace, market size and market growth
  • clock

    14:00

    The challenges of point of care testing

  • The advocates
  • The antagonists
  • The arguments for POCT – and the barriers against
  • The solutions for developing the point of care market
  • clock

    14:40

    The issues

  • Locations of POCT– how will they develop?
  • Hospital lab ‘rapid tests’
  • Hospital non-lab
  • Doctor’s office/laboratory
  • Other non-hospital POCT
  • Home monitoring and home ‘diagnosis’
  • Is technology development the key – advances in small meters, IT and ‘connectivity’; test strips and particles; biosensors and eventually – biochips…?
  • Regulatory changes – will they help create the opportunity?
  • clock

    15:20

    Afternoon Tea

    clock

    15:45

    Practical examples: e.g.

  • Clinical relevance of point of care (in vitro) testing versus in vivo Solutions
  • Cardiac markers in the ER, C-ICU, ambulance
  • Stomach ulcer testing in the doctor’s office
  • Drugs and Alcohol in the Workplace
  • Self Control of Diabetes and for Anticoagulation Therapy
  • Other examples, as time permits
  • clock

    16:15

    Review of topics, questions/answers

    clock

    17:00

    Close of Executive Briefing

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Doris-Ann Williams

    Doris-Ann Williams, Director General, British In Vitro Diagnostics Association (BIVDA)

    clock

    9:10

    KEYNOTE ADDRESS

    Harald Stock

    Harald Stock, Head of Global Business Development, Roche Diagnostocs GmbH

  • The global point of care marketplace
  • The shift from laboratory testing to point of care tests
  • The geographical split in the market
  • Emerging new technologies
  • The future of POCT
  • clock

    9:50

    REGULATIONS IN POCT

    Andrea Molyneaux

    Andrea Molyneaux, , Medicines and Healthcare Products Regulatory Agency (MHRA)

  • The marketplace
  • Reviewing current European regulations
  • The impact of regulations on the industry
  • Minimising regulatory barriers
  • Future plans and policies
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    RANGE OF POCT

    Dr Greg Shipp

    Dr Greg Shipp, Vice President, Medical Affairs, Abbott Point of Care (I-STAT) Division

  • The wide range of point of care assays – from A to Z
  • Differences in platforms and extent of testing on a single platform
  • Improvement in clinical outcomes with use of POCT
  • Future developments
  • clock

    11:40

    DRUGS OF ABUSE

    Dr Christopher Hand

    Dr Christopher Hand, Managing Director, Cozart

  • Oral fluid drug testing
  • Techniques involved
  • Functions in criminal justice, medical and at the roadside
  • Future developments
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    RAPID COAGULATION TESTING

    Professor Sam  Machin

    Professor Sam Machin, Consultant Haematologist, University College London Hospitals

  • The majority of POCT are performed on whole blood
  • Advantages of end-point measurements between clotting and bleeding
  • Growth of home self-testing equipment
  • Development of straightforward and swift response analysers
  • clock

    14:30

    PROMPT CARDIAC MARKER TESTS

    Dr Kenneth Buechler

    Dr Kenneth Buechler, Senior Vice President, Research & Development, Biosite

  • Fast diagnosis increases patients’ survival rates
  • Reduces unnecessary hospital admissions
  • Improvement of diagnosis using multiple markers
  • Future developments
  • clock

    15:10

    Afternoon Tea

    clock

    15:30

    RAPID HIV ANTIBODY TESTS

    Douglas Michels

    Douglas Michels, President & Chief Executive Officer, OraSure Technolgies

  • What are the current movements?
  • Analysis of the present market and growth potential
  • Advantages of POCT in this sector
  • Future plans
  • clock

    16:10

    IMMUNODIAGNOSTICS

    Svein Lien

    Svein Lien, Chief Executive Officer, Axis-Shield

  • The immunodiagnostic sector
  • Advantages for healthcare individuals
  • Market trends associated with immunodiagnostics
  • AFINION™ a new immunodiagnostic point of care system
  • clock

    16:50

    AFTER BLOOD GLUCOSE MONITORING

    Bill Cunningham

    Bill Cunningham, Managing Director, CDx

  • Analysing the sales structure of the current global point of care market
  • Essential requirements to make a major impact on sales
  • Sexually transmitted disease screening- a likely candidate?
  • clock

    17:00

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Re-registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Brian Fishwick

    Brian Fishwick, President, British In Vitro Diagnostic Association (BIVDA)

    clock

    9:10

    MICROFLUIDIC CHIPS FOR POINT OF CARE DIAGNOSTICS

    Dr Ralf-Peter Peters

    Dr Ralf-Peter Peters, Director, Microfluids Division, STEAG microParts

  • Addressing new opportunities in point of care with bioMEMS
  • Selecting a suitable technology platform
  • Development of novel diagnostic devices based on microfluidic design elements
  • Fabrication of microstructured plastic disposables
  • Examples of MEMS-based lateral flow assays for point of care
  • Partnership strategies for global commercialisation success
  • clock

    9:50

    NUCLEIC ACID AND PROTEIN ANALYSIS

    Dr John Clarkson

    Dr John Clarkson, Technical Director, Molecular Sensing

  • Advantages of fast analysis
  • Trends in the market
  • Levels of accuracy and sensitivity
  • Future developments
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    CRITICAL CARE

    Charles Mountain

    Charles Mountain, Vice President, Business Development & Technology, Instrumentation Laboratory

  • Needs in critical care testing
  • Point of care grows in response
  • Key advancements – menu, QA, connectivity
  • Standardised system for all testing locations
  • Future directions – further integration
  • clock

    11:40

    TRANSFERENCE OF PATIENT ANALYSIS

    Clint Severson

    Clint Severson, President & Chief Executive Officer, Abaxis

  • The financial advantages of POCT
  • Is the shift towards point of care justified?
  • Overall cost benefit
  • More available time for clinical practitioners
  • Future policies
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    INFORMATICS AND POCT

    Dr Andrew St John

    Dr Andrew St John, Consultant, ARC Consulting

  • The impact of informatics on POCT
  • Connectivity standards
  • Integration of POCT into healthcare systems
  • Delivery of evidence-based POCT
  • clock

    14:30

    HEALTH CONSEQUENCES ASSOCIATED WITH POCT

    Professor Christopher Price

    Professor Christopher Price, Vice President, Global Clinical Research, Diagnostics Division, Bayer Healthcare

  • How has this form of testing benefited the patient?
  • Practical evidence to clarify the advantages
  • Adapting clinical practices to incorporate POCT
  • Economic benefits of POCT
  • Future challenges and plans
  • clock

    15:10

    Afternoon Tea

    clock

    15:40

    EUROPEAN PERSPECTIVE ON PRICING AND REIMBURSEMENT

    Dr Raimund Sterz

    Dr Raimund Sterz, Director, Health Economics & Outcomes Research, Abbott

  • Reimbursement structure and organisation
  • Indications of pricing benefits
  • Perception of POCT in Europe
  • Long term gain of POCT
  • Forthcoming planning considerations
  • clock

    16:20

    PRICING AND REIMBURSEMENT ISSUES

    Dr Mark Charny

    Dr Mark Charny, Managing Director, Translucency

  • Pricing and reimbursement of POCT
  • Legislative reforms
  • Key trends from an NHS perspective
  • Future plans and policies
  • clock

    17:00

    Chairman's Closing Remarks and Close of Conference

    Workshops

    The Present Status and Future Prospects for POCT

    The Present Status and Future Prospects for POCT

    Jurys Great Russell Street Hotel
    22 February 2005
    London, United Kingdom

    Jurys Great Russell Street Hotel

    16-22 Great Russell Street
    London WC1B 3NN
    United Kingdom

    Jurys Great Russell Street Hotel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.